Evidence map›Paper›PMID 19720752›Full record

ArticleInfection and immunity2009

Yersinia pseudotuberculosis virulence determinants invasin, YopE, and YopT modulate RhoG activity and localization.

Sina Mohammadi, Ralph R Isberg

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 39 citations in OpenAlex.

  1. Current Challenges inMicroorganisms · 2025
    Review
  2. Article
  3. Review
  4. Review
  5. Microbiology spectrum · 2021
    Article
  6. Review
  7. Article
  8. Vav2 lacks CaJournal of cell science · 2020
    Article
  9. Article
  10. Review
  11. Article
  12. Yersinia type III effectors perturb host innate immune responses.World journal of biological chemistry · 2016
    Review
  13. ClipR-59 interacts with Elmo2 and modulates myoblast fusion.The Journal of biological chemistry · 2015
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Regulation of the Yersinia type III secretion system: traffic control.Frontiers in cellular and infection microbiology · 2013
    Review
  19. Yersinia pestis: mechanisms of entry into and resistance to the host cell.Frontiers in cellular and infection microbiology · 2013
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Sina MohammadiDepartment of Molecular Biology and Microbiology, Tufts University School ofMedicine, 150 Harrison Ave. J424, Boston, MA 02111, USA.
Ralph R Isberg
Howard Hughes Medical Institute · USTufts University · US

Funding

PILOT AND FEASIBILITY STUDIESP30DK034928 · NIDDK · TUFTS MEDICAL CENTER · PI PLAUT, ANDREW GEORGE · 1986 to 2007
$8.5M
MOLECULAR ANALYSIS OF MICROBIAL PATHOGENST32AI007422 · NIAID · TUFTS UNIVERSITY BOSTON · PI Ralph R. Isberg · 1992 to 2026
$5.7M
MOLECULAR BASIS OF YERSINIA/HOST CELL INTERACTIONR37AI023538 · NIAID · TUFTS UNIVERSITY BOSTON · PI ISBERG, RALPH R. · 2000 to 2009
$3.3M
Howard Hughes Medical InstituteNIAID NIH HHS 5T32AI007422NIAID NIH HHS R37 AI023538NIAID NIH HHS R37AI23538NIAID NIH HHS T32 AI007422NIDDK NIH HHS P30 DK034928NIDDK NIH HHS P30DK34928
6 · The paper itself

Abstract

The Yersinia pseudotuberculosis surface protein invasin binds to multiple beta1 integrins with high affinity, leading to misregulation of Rac1 activity. Upon host cell binding, alteration of Rho GTPase activity results from the action of several Yersinia outer proteins (Yops) that are translocated into the cytoplasm. We report here that three virulence determinants encoded by Y. pseudotuberculosis manipulate the Rho GTPase RhoG. Y. pseudotuberculosis binding to cells caused robust recruitment of RhoG to the site of attachment, which required high-affinity invasin-beta1 integrin association. Furthermore, inactivation of RhoG significantly reduced the efficiency of invasin-mediated bacterial internalization. To investigate the activation state of RhoG, a fluorescence resonance energy transfer-based activation biosensor was developed and used to show distinct spatial activation of RhoG at the site of bacterial attachment. The biosensor was also used to show efficient RhoG inactivation by Y. pseudotuberculosis YopE, a potent Rho GTPase activating protein. Additionally, RhoG mislocalization by the prenylcysteine endoprotease YopT was demonstrated by two independent assays. Functional bacterial uptake experiments demonstrated that RhoG activation can bypass a deficit in Rac1 activity. Interestingly, increasing the size of the particle gave results more consistent with a linear pathway, in which RhoG acts as an upstream activator of Rac1, indicating that increased surface area introduces constraints on the signaling pathways required for efficient internalization. Taken together, these data demonstrate the misregulation of RhoG by multiple Y. pseudotuberculosis virulence determinants. Since RhoG is imperative for proper neutrophil function, this misregulation may represent a unique mechanism by which Yersinia species dampen the immune response.

Indexed as

Adhesins, BacterialAnimalsBacterial Outer Membrane ProteinsBacterial ProteinsBiosensing TechniquesChlorocebus aethiopsCOS CellsCysteine EndopeptidasesEnzyme ActivationFluorescence Resonance Energy TransferHost-Parasite InteractionsHumansMicroscopyPhagosomesrac1 GTP-Binding Proteinrho GTP-Binding ProteinsAdhesins, BacterialBacterial Outer Membrane ProteinsBacterial ProteinsCysteine Endopeptidasesinvasin, Yersiniarac1 GTP-Binding Proteinrho GTP-Binding ProteinsVirulence FactorsyopE protein, YersiniaYopT protein, Yersinia

Identifiers

PMID19720752
PMCPMC2772528
OpenAlexW2148443839

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.